Page last updated: 2024-08-25

clarithromycin and carbamazepine

clarithromycin has been researched along with carbamazepine in 33 studies

Research

Studies (33)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (15.15)18.2507
2000's9 (27.27)29.6817
2010's15 (45.45)24.3611
2020's4 (12.12)2.80

Authors

AuthorsStudies
Li, Y; Li, YH; Wang, YH; Yang, L; Yang, SL1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Andricopulo, AD; Moda, TL; Montanari, CA1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Glen, RC; Lowe, R; Mitchell, JB1
Ekins, S; Williams, AJ; Xu, JJ1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Bharate, SS; Vishwakarma, RA1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Getz, HD; Metz, DC1
Boustany, RM; DeLong, GR; Loganbill, H; Nahouraii, R; Nohria, V; Stafstrom, CE1
Dammann, HG1
Kaneko, S; Ohkubo, T; Otani, K; Shimoyama, R; Sugawara, K; Yasui, N1
Alegre Herrera, S; Araujo Sanabria, J; Rubio Rubio, JM1
Badyal, DK; Garg, SK1
Delpierre, S; Karoubi, E; Lacaille, S; Leclercq, V; Legrain, S1
Akcay, A; Alkis, M; Bavbek, N; Kanbay, M; Turgut, F; Uz, E1
Coubes, P; Crespel, A; Gélisse, P; Halaili, E; Hillaire-Buys, D; Jean-Pastor, MJ; Vespignan, H1
Asmin, J; Escher, BI; Hollender, J; Kwon, JH; Steimen, I; Vermeirssen, EL1
De Saint Martin, A; Fischbach, M; Fothergill, H; Gerout, AC; Laugel, V; Perville, A; Santucci, R1
Baiocchi, C; Calza, P; Giancotti, V; Medana, C; Padovano, E1
Calza, P; Giancotti, V; Medana, C; Minero, C; Padovano, E1
Bianco, G; Buchicchio, A; Caniani, D; Masi, S; Sofo, A1
Aoki, H; Itai, S; Iwao, Y; Mizoguchi, M; Noguchi, S; Watanabe, M1
Hwang, SH; Jung, HJ; Kang, TW; Kim, K; Lee, KH; Na, TW1
Bianco, G; Bufo, SA; Caniani, D; Coviello, D; Cristina Lafiosca, M; Mancini, IM; Masi, S; Pascale, R; Scrano, L1
Chaturvedula, A; Cicali, B; Cristofoletti, R; Hoechel, J; Lingineni, K; Schmidt, S; Vozmediano, V; Wendl, T; Wiesinger, H1
Fernandes, TV; Langenhoff, A; Rijnaarts, H; Tizzani, R; Wu, K; Zweers, H1
Abraham, TL; Bedwell, DW; Hall, SD; Hansen, K; Rougée, LRA1

Reviews

1 review(s) available for clarithromycin and carbamazepine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

32 other study(ies) available for clarithromycin and carbamazepine

ArticleYear
Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism.
    Bioorganic & medicinal chemistry letters, 2005, Sep-15, Volume: 15, Issue:18

    Topics: Computational Biology; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Molecular Structure; Principal Component Analysis; Pyrrolizidine Alkaloids; Quantitative Structure-Activity Relationship; Reproducibility of Results; Substrate Specificity; Venlafaxine Hydrochloride

2005
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
Predicting phospholipidosis using machine learning.
    Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5

    Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
    Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

    Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection

2012
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
    Bioorganic & medicinal chemistry letters, 2015, Apr-01, Volume: 25, Issue:7

    Topics: Drug Discovery; Pharmaceutical Preparations; Solubility; Thermodynamics

2015
Helicobacter pylori gastritis therapy with omeprazole and clarithromycin increases serum carbamazepine levels.
    Digestive diseases and sciences, 1995, Volume: 40, Issue:4

    Topics: Adult; Carbamazepine; Clarithromycin; Drug Interactions; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Tetracycline

1995
Erythromycin-induced carbamazepine toxicity: a continuing problem.
    Archives of pediatrics & adolescent medicine, 1995, Volume: 149, Issue:1

    Topics: Adolescent; Carbamazepine; Child; Child, Preschool; Clarithromycin; Drug Interactions; Epilepsy; Erythromycin; Female; Humans; Male

1995
Therapy with omeprazole and clarithromycin increases serum carbamazepine levels in patients with H. pylori gastritis.
    Digestive diseases and sciences, 1996, Volume: 41, Issue:3

    Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Carbamazepine; Clarithromycin; Drug Interactions; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole

1996
Carbamazepine toxicity induced by clarithromycin coadministration in psychiatric patients.
    International clinical psychopharmacology, 1997, Volume: 12, Issue:4

    Topics: Aged; Anti-Bacterial Agents; Anticonvulsants; Bipolar Disorder; Carbamazepine; Central Nervous System Diseases; Clarithromycin; Drug Interactions; Female; Humans; Male; Middle Aged; Pneumonia; Psychotic Disorders

1997
[Clarithromycin-carbamazepine interaction: neurological symptoms and hyponatremia].
    Anales de medicina interna (Madrid, Spain : 1984), 1998, Volume: 15, Issue:1

    Topics: Anti-Bacterial Agents; Anticonvulsants; Carbamazepine; Clarithromycin; Drug Interactions; Humans; Hyponatremia; Male; Middle Aged; Nervous System Diseases

1998
Effect of clarithromycin on the pharmacokinetics of carbamazepine in rhesus monkeys.
    Methods and findings in experimental and clinical pharmacology, 2000, Volume: 22, Issue:7

    Topics: Animals; Anti-Bacterial Agents; Anticonvulsants; Carbamazepine; Clarithromycin; Drug Interactions; Macaca mulatta; Male

2000
[Avoidable adverse event: carbamazepine encephalopathy when introducing clarithromycine].
    La Revue de medecine interne, 2005, Volume: 26, Issue:10

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antimanic Agents; Bipolar Disorder; Brain Diseases; Bronchitis; Carbamazepine; Clarithromycin; Drug Interactions; Electroencephalography; Humans; Iatrogenic Disease; Male; Time Factors

2005
Hyponatremia due to an additive effect of carbamazepine and clarithromycin.
    Southern medical journal, 2007, Volume: 100, Issue:2

    Topics: Adult; Anti-Bacterial Agents; Anticonvulsants; Carbamazepine; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Epilepsy; Female; Humans; Hyponatremia; Sinusitis; Sodium

2007
[Carbamazepine and clarithromycin: a clinically relevant drug interaction].
    Revue neurologique, 2007, Volume: 163, Issue:11

    Topics: Adult; Aged; Anti-Bacterial Agents; Anticonvulsants; Carbamazepine; Clarithromycin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Overdose; Epilepsies, Partial; Epilepsy; Epilepsy, Frontal Lobe; Female; Humans; Infant; Male

2007
The role of hydrodynamics, matrix and sampling duration in passive sampling of polar compounds with Empore SDB-RPS disks.
    Journal of environmental monitoring : JEM, 2008, Volume: 10, Issue:1

    Topics: Carbamazepine; Clarithromycin; Environmental Monitoring; Estrogens; Pharmaceutical Preparations; Rivers; Sulfamethoxazole; Water Movements; Water Pollutants, Chemical; Yeasts

2008
The onset of acute oxcarbazepine toxicity related to prescription of clarithromycin in a child with refractory epilepsy.
    British journal of clinical pharmacology, 2010, Volume: 69, Issue:3

    Topics: Carbamazepine; Child; Clarithromycin; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Epilepsy; Humans; Oxcarbazepine

2010
Identification of the unknown transformation products derived from clarithromycin and carbamazepine using liquid chromatography/high-resolution mass spectrometry.
    Rapid communications in mass spectrometry : RCM, 2012, Aug-15, Volume: 26, Issue:15

    Topics: Carbamazepine; Carbon; Chromatography, Liquid; Clarithromycin; Hydroxylation; Mass Spectrometry; Photolysis; Water Pollutants, Chemical

2012
Fate of selected pharmaceuticals in river waters.
    Environmental science and pollution research international, 2013, Volume: 20, Issue:4

    Topics: Anti-Bacterial Agents; Anticonvulsants; Carbamazepine; Chromatography, High Pressure Liquid; Clarithromycin; Environmental Monitoring; Italy; Lincomycin; Mass Spectrometry; Photolysis; Rivers; Water Pollutants, Chemical; Water Pollution, Chemical

2013
Biodegradation of carbamazepine and clarithromycin by Trichoderma harzianum and Pleurotus ostreatus investigated by liquid chromatography - high-resolution tandem mass spectrometry (FTICR MS-IRMPD).
    The Science of the total environment, 2016, 07-01, Volume: 557-558

    Topics: Biodegradation, Environmental; Carbamazepine; Chromatography, High Pressure Liquid; Chromatography, Liquid; Clarithromycin; Pleurotus; Spectrometry, Mass, Electrospray Ionization; Trichoderma; Wastewater; Water Pollutants, Chemical

2016
Saturated fatty acids and fatty acid esters promote the polymorphic transition of clarithromycin metastable form I crystal.
    International journal of pharmaceutics, 2016, Oct-15, Volume: 512, Issue:1

    Topics: Carbamazepine; Clarithromycin; Crystallization; Esters; Fatty Acids; Nifedipine; Phase Transition; Transition Temperature

2016
Distribution and ecological risk of pharmaceuticals in surface water of the Yeongsan river, Republic of Korea.
    Ecotoxicology and environmental safety, 2019, Oct-15, Volume: 181

    Topics: Carbamazepine; Chromatography, Liquid; Clarithromycin; Ecosystem; Environmental Monitoring; Naproxen; Pharmaceutical Preparations; Republic of Korea; Risk Assessment; Rivers; Sulfamethoxazole; Tandem Mass Spectrometry; Wastewater; Water Pollutants, Chemical

2019
Validation of a liquid chromatography coupled with tandem mass spectrometry method for the determination of drugs in wastewater using a three-phase solvent system.
    Journal of separation science, 2020, Volume: 43, Issue:5

    Topics: Amoxicillin; Carbamazepine; Chromatography, Liquid; Clarithromycin; Erythromycin; Metformin; Particle Size; Solvents; Surface Properties; Tandem Mass Spectrometry; Wastewater; Water Pollutants, Chemical

2020
Quantitative Assessment of Levonorgestrel Binding Partner Interplay and Drug-Drug Interactions Using Physiologically Based Pharmacokinetic Modeling.
    CPT: pharmacometrics & systems pharmacology, 2021, Volume: 10, Issue:1

    Topics: Adult; Alkynes; Benzoxazines; Body Mass Index; Carbamazepine; Clarithromycin; Computer Simulation; Contraceptives, Oral, Combined; Cyclopropanes; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Humans; Itraconazole; Levonorgestrel; Models, Biological; Obesity; Rifampin; Sex Hormone-Binding Globulin

2021
Removal processes of individual and a mixture of organic micropollutants in the presence of Scenedesmus obliquus.
    The Science of the total environment, 2022, Sep-10, Volume: 838, Issue:Pt 4

    Topics: Carbamazepine; Chlorophyceae; Clarithromycin; Diclofenac; Metoprolol; Microalgae; Scenedesmus; Wastewater; Water Pollutants, Chemical

2022
Impact of Heterotropic Allosteric Modulation on the Time-Dependent Inhibition of Cytochrome P450 3A4.
    Drug metabolism and disposition: the biological fate of chemicals, 2023, Volume: 51, Issue:10

    Topics: Carbamazepine; Clarithromycin; Cytochrome P-450 CYP3A; Drug Interactions; Humans; Microsomes, Liver; Midazolam; Troleandomycin

2023